Decursin and decursinol angelate inhibit VEGF-induced angiogenesis via suppression of the VEGFR-2-signaling pathway. (Q51812427)

13 April 2018

title

Decursin and decursinol angelate inhibit VEGF-induced angiogenesis via suppression of the VEGFR-2-signaling pathway. (English)

1 reference

13 April 2018

author name string

Myung Hwan Jung

1

1 reference

13 April 2018

Sun Hee Lee

2

1 reference

13 April 2018

Eun-Mi Ahn

3

1 reference

13 April 2018

You Mie Lee

4

1 reference

13 April 2018

language of work or name

English

0 references

publication date

18 February 2009

1 reference

13 April 2018

published in

Carcinogenesis

1 reference

13 April 2018

volume

30

1 reference

13 April 2018

issue

4

1 reference

13 April 2018

page(s)

655-661

1 reference

13 April 2018

What Is the Evidence That Tumors Are Angiogenesis Dependent?

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP039

The implications of angiogenesis for the biology and therapy of cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP039

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP039

Tumor angiogenesis: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP039

Expression of vascular endothelial growth factor (VEGF) family members in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP039

VEGF receptor signaling in tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP039

Anti-tumor activities of decursinol angelate and decursin fromAngelica gigas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP039

Decursin from Angelica gigas mitigates amnesia induced by scopolamine in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP039

Nodakenin, a coumarin compound, ameliorates scopolamine-induced memory disruption in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP039

Involvement of PKC and ROS in the cytotoxic mechanism of anti-leukemic decursin and its derivatives and their structure-activity relationship in human K562 erythroleukemia and U937 myeloleukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP039

Low energy proton beam induces tumor cell apoptosis through reactive oxygen species and activation of caspases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP039

The phosphatidylinositol-3 kinase/Akt pathway mediates VEGF's neuroprotective activity and induces blood brain barrier permeability after focal cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP039

Minocycline exerts multiple inhibitory effects on vascular endothelial growth factor-induced smooth muscle cell migration: the role of ERK1/2, PI3K, and matrix metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP039

Structure and function of VEGF/VEGF-receptor system involved in angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP039

VEGFs, receptors and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP039

Development of angiogenesis inhibitors to vascular endothelial growth factor receptor 2. Current status and future perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP039

Clinical development of angiogenesis inhibitors to vascular endothelial growth factor and its receptors as cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP039

Monoclonal antibody strategies to block angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP039

c-JUN gene induction and AP-1 activity is regulated by a JNK-dependent pathway in hypoxic HepG2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP039

Activation of stat3 in human melanoma promotes brain metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP039

Specific blockade of the ERK pathway inhibits the invasiveness of tumor cells: down-regulation of matrix metalloproteinase-3/-9/-14 and CD44

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP039

Downregulation of MMP-9 in ERK-mutated stable transfectants inhibits glioma invasion in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP039

Src oncogene activates MMP-2 expression via the ERK/Sp1 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP039

Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP039

Decursin and decursinol angelate inhibit estrogen-stimulated and estrogen-independent growth and survival of breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP039

A novel class of pyranocoumarin anti-androgen receptor signaling compounds.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP039

Potent antiandrogen and androgen receptor activities of an Angelica gigas-containing herbal formulation: identification of decursin as a novel and active compound with implications for prevention and treatment of prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP039

Vascular Endothelial Growth Factor Induction of the Angiogenic Phenotype Requires Ras Activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP039

Coumarins from the Root of Angelica gigas NAKAI

21 January 2018

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1248/CPB.16.1139

Identifiers

DOI

10.1093/CARCIN/BGP039

1 reference

13 April 2018

1 reference

13 April 2018